Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
53.94
+0.95 (1.79%)
At close: Jun 5, 2025, 4:00 PM
53.88
-0.06 (-0.11%)
Pre-market: Jun 6, 2025, 6:20 AM EDT
Akero Therapeutics Market Cap
Akero Therapeutics has a market cap or net worth of $4.30 billion as of June 6, 2025. Its market cap has increased by 208.75% in one year.
Market Cap
4.30B
Enterprise Value
3.21B
1-Year Change
208.75%
Ranking
Category
Stock Price
$53.94
Market Cap Chart
Since June 20, 2019, Akero Therapeutics's market cap has increased from $495.47M to $4.30B, an increase of 767.86%. That is a compound annual growth rate of 43.66%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 685.14B |
Johnson & Johnson | 369.38B |
AbbVie | 332.24B |
Novo Nordisk | 324.15B |
UnitedHealth Group | 269.45B |
Abbott Laboratories | 232.77B |
Novartis AG | 229.87B |
AstraZeneca | 226.47B |